Coherus Loses Bid To Shift Fees To Amgen In Patent Suit
A U.S. District Court judge in Delaware on Monday shot down Coherus BioSciences Inc.'s bid to shift legal fees to Amgen Inc. in its failed patent infringement suit against Coherus over...To view the full article, register now.
Already a subscriber? Click here to view full article